• Principal Investigator for the project entitled ‘Evaluation of Drug Utilization Patterns among Elderly Patients’ funded by the Indian Council of Medical Research (ICMR), New Delhi, with a budget of Rs. 5,71,250/- (February 2019 to January 2020) (No. 70/03/2017/BMS/DUR dated 22/03/2017)

• Organizing Secretary for the ‘Advanced Level Training Program on Pharmacovigilance for Healthcare Professionals in Northeast India’ organized by the Department of Pharmacy Practice, NIPER Guwahati, on 1st & 2nd March, 2024, funded by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India with a budget of Rs. 1,87,500/- (No. 35025/12/2023-Scheme) 

Clinical Research Coordinator - A Double-blind, Randomized, Parallel Group Study Comparing the Pharmacokinetics, Pharmacodynamics, Safety, Efficacy, and Immunogenicity of Three Anti-CD20 Monoclonal Antibodies in Patients with Moderate to Severe Active, Seropositive Rheumatoid Arthritis with an Inadequate Response to Methotrexate Based Therapy - Phase IV Study (DRL-RI-01-003); 1st August 2014 to 12th December 2017 

1. Assessment of Prevalence, Risk Factors, and Biomarkers for Connective Tissue Disorders Related Interstitial Lung Disease: A Prospective Observational Cohort Study – Rathod Mahesh (2022 Batch) 

2. Assessment of Potential Risk Factors and Biomarkers for Refractory Epilepsy – Ruby Kasana (2021 Batch)

3. Assessment of Prevalence, Risk Factors, Management and Economic Burden of Gall Bladder Cancer Among Northeast Population of India: A Hospital-Based Prospective Observational Cohort Study – Christy Thomas (2020 Batch)

1. Target Fishing and Drug Repurposing for Gallbladder Cancer: An Integrated Bioinformatic and Pharmacovigilance Approach - Vismitha Varghese - 2024

2. Comprehensive Assessment of Characteristics, Risk Factors and Functional Status of Stroke Patients - Sneha Mariam Biju - 2024

3. Identifying the Safety Signals Associated with Ferric Carboxymaltose: A Disproportionality Analysis of Spontaneous Reports and Extensive Systematic Review - Galigutta Reddikumar Reddy - 2024

4. Survival Prediction and Economic Implications of Oropharyngeal Squamous Cell Carcinoma - Keerthi Raj - 2024

5. Assessment of Adverse Events in Cancer Chemotherapy: Focus on Ocular Toxicity with Platinum Agents - Hasik P N - 2024

6. Assessment of Spectrum and Pharmacoeconomic Aspects of Neurological Disorders in a Tertiary Care Hospital - Haripriya N B - 2024

7. Longevity of Systematic Reviews of Parp Inhibitors in Ovarian Cancer - Varri Naga Gowthami – 2024 

8. Implementation of Clinical Pharmacist’s Services in Patients Receiving Oral Oncolytics and Its Effects on Medication Adherence and Quality of Life: A Hospital Based Prospective Interventional Study – Aditi Battu - 2023

9. Assessment of the Disease Pattern and Drug Utilization among the Neuro ICU Patients – Mamidi Niveditha - 2023

10. Assessment of Potential Risk Factors and Biomarkers for the Interstitial Lung Disease in Patients with Rheumatoid Arthritis – Chunduri Preethi - 2023

11. Evaluation of Productivity Losses due to Premature Mortality from Head and Neck Cancer in Northeast India: A Population-Based Cost Analysis – Shilpa A - 2023

12. Evaluation and Reporting of Adverse Drug Reactions for Cancer Chemotherapeutic Agents: A Tertiary Care Cancer Speciality Hospital-Based Observational Study – Syed Kashif Ali - 2023

13. Economic Burden of Gallbladder Cancer in Northeast India: A Hospital-Based Prospective Observational Cost Analysis Study – Vijayasangeetha G - 2023

14. Risk of Pancreatitis and Pancreatic Carcinoma for Anti-diabetic Medications: Evidence Synthesis from Disproportionality Analysis and Systematic Review of Randomized Controlled Trials - Asif Muhammed - 2022

15. Cardiovascular Efficacy and Safety of Incretin Mimetics and Sodium-Glucose Co-Transporter 2 Inhibitors as an Add-On to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials - Gifty Lawrance - 2022

16. The Quality of Reporting Methods and Results of Cost-Effectiveness Analyses Conducted in India: A Methodological Systematic Review - Karun Donthineni - 2022

17. Risk of Adverse Events Associated with Novel Oral Anticoagulants: A Systematic Review and Network Meta-analysis - Amar Ashok Maske - 2022

18. Quality Assessment of Latest Oncology Guidelines and Systematic Reviews Referenced in these Guidelines – Nethravathi - 2022

19. Identification of Novel Safety Signals of SGLT2 Inhibitors: An Analysis of USFDA and Global Safety Databases – Hibathulla P – 2021

20. To Identify the Implementation of Indian Specific Drug Safety Signals/Prescribing Information Leaflets Changes: Comparison with Other Countries – Saphal Surendran – 2021

21. Quality Assessment of Research Articles Published on COVID-19 – Athira S Joshy – 2021

22. Efficacy and Safety of Isoniazid Preventive Therapy in People Living with HIV: A Systematic Review and Meta-analysis – J Jaya Laxmi – 2021

23. Drugs Banned in Other Countries but Still Available in India: Facts and Figures – Kamsuthong W Tikhir – 2021

24. Efficacy and Safety of Amphotericin B and Oral Miltefosine Combination Therapy in Patients with Leishmaniasis: A Systematic Review and Meta-analysis - Mandava Satish – 2021

25. Evaluation of Antibiotic Use in the Neonatal Intensive Care Unit of a Tertiary Care Hospital: A Prospective Observational Cohort Study - Ritesh M Rajpara – 2020

26. The Safety of Nitrofurantoin during the Third Trimester of Pregnancy: A Prospective Observational Cohort Study – Bini Kurien – 2019

27. A Study on Drug-Drug Interactions among Patients with Cardiovascular Diseases - Asmita Priyadarshini K. – 2019

28. Assessment of Knowledge, Beliefs and Practice about Medication Use among Pregnant Women – Nicy Joy – 2018 (Co-Guide)

29. Medication Use Evaluation in Neonatal Intensive Care Unit of a Tertiary Care Hospital: A Prospective Observational Study – Bashar Talal Saad Mohammed – 2017 (Co-Guide) 

1. Estimation of cardiovascular risk among patients admitted to south Indian tertiary care hospital - Ida Ann Cherian, Perpetua Ezinne Nnachi, Shilpa K., Sneha Joy – 2020

2. Drug utilization evaluation in patients with acute coronary syndrome - Jithendra Patel B, Vishal S Vinod, Ray Mahima Janardhan, Mandalapu Laasya – 2019

3. Assessment of Treatment Patterns of Diabetic Foot Ulcer in a Tertiary Care Hospital - Nisha Kushnoor, Rinsa Cherian A, Saranya Krishnan, Vinodhini V. – 2018

4. Impact of a Clinical Pharmacist-Led Post-Hospitalization Care on Clinical Outcomes, Health-Related Quality of Life and Knowledge among Patients with Acute Coronary Syndrome: A Randomized Controlled Study – Sherin Babu, Abdhija Garikiparthi, George Mathew Panachiyil, K. Deepak Kumar – 2018

5. Risk Factors for Adverse Birth Outcomes: A Population based Case-Control Study in a Tertiary Care Hospital – Dawn Shaji, Krupa Sagar Yarlagadda, Ritesh Giri, Tessy Mariya Jose – 2016 (Co-Guide)

6. Medication Related Falls among Elderly – Prevalence, Nature, Cost Implications and Risk Factors – Perumalla Rajasekhar, Puvvada Rahul Krishna, Reshma Merin Reji, K.P. Pallavi – 2015 (Co-Guide) 

1. Assessment of knowledge and perception towards self-medication among healthcare students. Aathira P Suresh, Akhila Jose, Bhavatharani T, Remy Mathew George, Riya James - 2020

2. Assessment of knowledge and perception towards generic medicines among pharmacy students - Abhinand E, Jobin Jose, Amal Raju, Ditty Varghese, Fathimathul Ajeena – 2019

3. Utilization Evaluation of Pain Management Medications in Cancer Patients - Aksa Mary Joseph, Ann Mariya Jose, Famna Roohi NK, Soumiya L A, Arun V R – 2018